Fertility Treatment for multiple failed pregnancies in Dubai
Having a child is the most precious feeling and it can be emotionally devastating to learn about a failed pregnancy. If the same happens multiple times, it might lead to couples giving up hope altogether and also affect their inter-personal relationship. If you are looking for multiple miscarriage treatment in Dubai, then you have come to the right place. Before we delve into how fertility treatment can help with multiple failed pregnancies, let us try & understand what exactly is a failed pregnancy& what can be the reason behind it.
First of all, a miscarriage is more common than you think. Did you know about 1/3 to 1/2 of all pregnancies end in miscarriage before a woman misses a menstrual period thus not even realizing that she was pregnant. About 10 to 20% of women who know they are pregnant will miscarry. The number diminishes drastically after 20 weeks’ gestation as only 1% miscarriages occur after this time period and are termed as late miscarriages.
The underlying cause for a miscarriage might vary from individual to individual but some of the most common reasons include:
- Age of the woman
- An underlying infection
- Improper implantation of fertilized egg in the uterine lining
- The cervix begins to widen and open too early, in the middle of pregnancy, without signs of pain or labor
- Disorders of the immune or an autoimmune disease
- Lifestyle factors such as smoking, drinking alcohol, or using illegal drugs
- Uncontrolled diabetes
- Hormonal irregularities
- Severe kidney disease
- Exposure to environmental and workplace hazards such as high levels of radiation or toxic agents.
Now that we understand miscarriages are common, they can be easily overcome with certain changes in lifestyle and expert consultation. But how does one go about in a situation where a miscarriage has happened multiple times?
The American Society of Reproductive Medicine (ASRM) has recently defined recurrent pregnancy loss as two or more pregnancy losses.
At MMC IVF, The treatment recommendations for patients with recurrent pregnancy loss are based on the underlying cause of recurrent pregnancy loss. The process begins with a physician taking a detailed medical, surgical, family, and genetic history and perform a physical examination. Testing that may be done includes karyotype analysis of both partners. The karyotype is the chromosomal, or genetic, make-up of a person. The purpose is to find abnormalities in the parents that could be passed on to the offspring, resulting in miscarriage. Because karyotype abnormalities are relatively rare, a doctor may choose to not perform this test unless other, more common, abnormalities are ruled out.An ultrasound is often done as a first test. The ultrasound can give information about the shape of the uterus and the presence of fibroids (benign round muscle tumors).
Tests of hormone function may also be done. Thyroid function tests and thyroid antibodies may be checked, along with measurement of prolactin, the hormone responsible for breast milk production. Ovarian reserve tests may be performed, which indicate how well an ovary is functioning. Some studies indicate that poorer ovarian function, as shown by these hormone tests, may be related to chromosomal abnormalities of the eggs in the ovary. Testing for diabetes may be done if a woman is at risk for or has manifestations of diabetes.
Individuals in whom a karyotypic (a chromosomal or genetic) abnormality is found are often referred for genetic counseling. There, a specialist can discuss what the genetic abnormality is and the likelihood of having a chromosomally normal or abnormal pregnancy in the future.Some affected couples may choose to undergo prenatal genetic studies during pregnancy to check the genetic make-up of the offspring with either 1) chorionic villus sampling (CVS), in which a piece of placenta is biopsied late in the first trimester or early in the second trimester, or 2) amniocentesis, which removes some of the amniotic fluid (the fluid that surrounds the baby during pregnancy) for analysis. In vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD) can also be done.
If a uterine abnormality is found, surgery may be performed depending on the defect. If antiphospolipid syndrome is diagnosed, certain medications that reduce blood clot formation may be given. If thyroid dysfunction or diabetes are diagnosed, specific medications can be prescribed.
To lead you on the right path of fertility treatment, MMC IVF is offering you an opportunity to consult with a world-class fertility specialists for a one-on-one discussion. You can also avail an exclusive ‘Get treatment now & pay Later’ plan. All you have to do is make an appointment with us +971 56 136 2512 or write to us at [email protected]. We will get back to you promptly. The best part is that you can stay at home and talk to our specialists online. In addition, you can request for a second opinion on the diagnosis and treatment you already are on. Reach out to MMC IVF and we will fix an appointment for it. visit this website:- https://www.mmcivf.com
7Reasons to consider frozen embryo transfer A procedure followed after an in-vitro fertilization (IVF) treatment, Embryo freezing (fertilized egg freezing) is done when there are additional embryos that you want to preserve.
However, even if you aren’t ready for IVF, you may choose to freeze embryos rather than eggs for future IVF treatments.
Now that we have got that out of our way, let’s move on to why embryo freezing is preferred today by couples who intend to start a family.
Less Medication– As the embryos are already frozen, the patient needs to undergo less medication when compared to going in for a fresh embryo transfer.
Instead of stimulation medication, patients use estrogen and progesterone to thicken the lining of their uterus in preparation for the embryo transfer to allow implantation.
Since the stimulation phase was done in a prior cycle, there is also no egg retrieval requiring anesthesia.
The latest trending report Global In-Vitro Fertilization (IVF) Market 2020 by Manufacturers Regions Type and Application Forecast to 2025 offered by DecisionDatabases.com is an informative study covering the market with detailed analysis.
The report will assist reader with better understanding and decision making.The global In-Vitro Fertilization (IVF) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 19020 million by 2025, from USD 15340 million in 2019.The In-Vitro Fertilization (IVF) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.Final Report will cover the impact of COVID-19 on this industry.Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/31900-in-vitro-fertilization-ivf-market-analysis-reportThe major players covered in In-Vitro Fertilization (IVF) are:OvaScienceThermo Fisher Scientific Inc.Irvine ScientificEMD Serono Inc.Genea BiomedxVitrolife ABBoston IVFCooper Surgical Inc.Cook Medical Inc.Progyny Inc.By Type, In-Vitro Fertilization (IVF) market has been segmented into: Culture Media Disposable Devices Capital EquipmentBy Application, In-Vitro Fertilization (IVF) has been segmented into: Fertility Clinics Hospitals Surgical Centers Clinical Research InstitutesThe report offers in-depth assessment of the growth and other aspects of the In-Vitro Fertilization (IVF) market in important countries (regions), including: North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Download Free Sample Report of Global In-Vitro Fertilization (IVF) Market @ https://www.decisiondatabases.com/contact/download-sample-31900There are 14 Chapters to deeply display the global In-Vitro Fertilization (IVF) market.1 In-Vitro Fertilization (IVF) Market Overview2 Company Profiles3 Global In-Vitro Fertilization (IVF) Market Competition, by Players4 Global In-Vitro Fertilization (IVF) Market Size by Regions5 North America In-Vitro Fertilization (IVF) Revenue by Countries6 Europe In-Vitro Fertilization (IVF) Revenue by Countries7 Asia-Pacific In-Vitro Fertilization (IVF) Revenue by Countries8 South America In-Vitro Fertilization (IVF) Revenue by Countries9 Middle East and Africa Revenue In-Vitro Fertilization (IVF) by Countries10 Global In-Vitro Fertilization (IVF) Market Segment by Type11 Global In-Vitro Fertilization (IVF) Market Segment by Application12 Global In-Vitro Fertilization (IVF) Market Size Forecast (2021-2025)13 Research Findings and Conclusion14 AppendixPurchase the complete Global In-Vitro Fertilization (IVF) Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-31900Other Reports by DecisionDatabases.com:Global In-vitro Toxicology Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025Global In Vitro Protein Expression Market 2019 by Company, Regions, Type and Application, Forecast to 2024About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
We provide intellectual, precise and meaningful data at a lightning speed.For more details:DecisionDatabases.comE-Mail: [email protected]: +91 9028057900Web: https://www.decisiondatabases.com/
